VMP 42137711000001103

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Topiramate 50mg tablets
BNF code 040801050AAAAAA
Virtual Therapeutic Moiety Topiramate
Date identifier became valid 4 Aug 2023
Previous product identifier 323023006
Basis of preferred name rINN - Recommended International Non-proprietary
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units tablet
Unit dose unit of measure tablet
Virtual Product Ingredient
Ingredient Topiramate
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 50.000
Strength value numerator unit mg
Ontology Drug Form & Route
Form & Route tablet.oral
Dose Form
Formulation Oral tablet
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Topamax 50mg tablets (CST Pharma Ltd)
Topamax 50mg tablets (Janssen-Cilag Ltd)
Topamax 50mg tablets (Pilsco Ltd)
Topamax 50mg tablets (Sigma Pharmaceuticals Plc)
Topiramate 50mg tablets (A A H Pharmaceuticals Ltd)
Topiramate 50mg tablets (Accord-UK Ltd)
Topiramate 50mg tablets (Alissa Healthcare Research Ltd)
Topiramate 50mg tablets (Alliance Healthcare (Distribution) Ltd)
Topiramate 50mg tablets (Crescent Pharma Ltd)
Topiramate 50mg tablets (Ennogen Healthcare Ltd)
Topiramate 50mg tablets (Medihealth (Northern) Ltd)
Topiramate 50mg tablets (Milpharm Ltd)
Topiramate 50mg tablets (Morningside Healthcare Ltd)
Topiramate 50mg tablets (Phoenix Healthcare Distribution Ltd)
Topiramate 50mg tablets (Torrent Pharma (UK) Ltd)
Virtual Medicinal Product Packs
Topiramate 50mg tablets 28 tablet
Topiramate 50mg tablets 56 tablet
Topiramate 50mg tablets 60 tablet

dm+d data retrieved from TRUD: release NHSBSA_4.3.0_20240422000001, imported on 22nd April 2024 at 05:06:50.

Feedback